Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewoud-Jan van Hoogdalem

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Antimicrobial Agents and Chemotherapy|March 29, 2023
Safety and Pharmacokinetics of Intravenous and Oral Fosmanogepix, a First-in-Class Antifungal Agent, in Healthy VolunteersMichael R Hodges, Eric Ople, Pamela Wedel, et al.
Current Clinical Pharmacology|October 19, 2019
First-in-Human Study of the Safety, Tolerability, Pharmacokinetics and - Preliminary Dynamics of Neuroprotectant 2-Iminobiotin in Healthy SubjectsEwoud-Jan van Hoogdalem, Cacha M P C D Peeters-Scholte, Paul W T J Leufkens, et al.
Science Translational Medicine|April 28, 2017
Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustionShenghui He, Patrick J Roberts, Jessica A Sorrentino, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Antimicrobial Agents and Chemotherapy|March 29, 2023
Safety and Pharmacokinetics of Intravenous and Oral Fosmanogepix, a First-in-Class Antifungal Agent, in Healthy VolunteersMichael R Hodges, Eric Ople, Pamela Wedel, et al.
Current Clinical Pharmacology|October 19, 2019
First-in-Human Study of the Safety, Tolerability, Pharmacokinetics and - Preliminary Dynamics of Neuroprotectant 2-Iminobiotin in Healthy SubjectsEwoud-Jan van Hoogdalem, Cacha M P C D Peeters-Scholte, Paul W T J Leufkens, et al.
Science Translational Medicine|April 28, 2017
Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustionShenghui He, Patrick J Roberts, Jessica A Sorrentino, et al.
Pageof 2